We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+37.87%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.28B
AUM Growth
+$56.1M
(+4.6%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-13.88%
Top 10 Holdings %
Top 10 Hldgs %
24.2%
Holding
156
New
50
Increased
25
Reduced
32
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Airbnb
ABNB
|
+$21M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$15.2M |
| 3 |
PayPal
PYPL
|
+$14.9M |
| 4 |
Morgan Stanley
MS
|
+$14M |
| 5 |
Shift4
FOUR
|
+$13.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$17.6M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$16M |
| 3 |
Enphase Energy
ENPH
|
+$15.6M |
| 4 |
XYZ
Block Inc
XYZ
|
+$14.6M |
| 5 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
+$14.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.79% |
| 2 | Technology | 24.19% |
| 3 | Consumer Discretionary | 14.84% |
| 4 | Communication Services | 10.24% |
| 5 | Financials | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Solid Biosciences
SLDB
$900M
| $1.92M | 0.15% |
+16,858
| New | +$1.07M |
|
102
Outset Medical
OM
$90.8M
| $1.85M | 0.15% |
2,173
-2,294
| -51% | -$1.77M |
|
103
CarMax
KMX
$8.26B
| $1.79M | 0.14% |
+19,000
| New | +$1.78M |
|
104
CALL
BioLife Solutions
BLFS
$1.7B
| $1.59M | 0.12% |
+40,000
| New | +$1.36M |
|
105
GoodRx Holdings
GDRX
$1.26B
| $879K | 0.07% |
21,795
-28,205
| -56% | -$1.3M |
|
|
FPRX
106
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $872K | 0.07% |
+51,273
| New | +$642K |
|
107
Calix
CALX
$2.39B
| $579K | 0.05% |
+19,447
| New | +$480K |
|
|
108
CALL
Solid Biosciences
SLDB
$900M
| $340K | 0.03% |
+2,993
| New | +$189K |
|
109
CALL
8x8 Inc
EGHT
$332M
| $249K | 0.02% |
+7,200
| New | +$154K |
|
110
CALL
Acadia Pharmaceuticals
ACAD
$5.03B
| – | – |
-50,000
| Closed | -$2.06M |
|
111
American Well
AMWL
$230M
| – | – |
-500
| Closed | -$296K |
|
|
AZEK
112
DELISTED
The AZEK Co
AZEK
| – | – |
-202,100
| Closed | -$7.04M |
|
113
Beyond Meat
BYND
$277M
| – | – |
-75,970
| Closed | -$12.6M |
|
114
Carrier Global
CARR
$52.8B
| – | – |
-259,000
| Closed | -$7.91M |
|
115
CALL
CRISPR Therapeutics
CRSP
$5.17B
| – | – |
-35,000
| Closed | -$2.93M |
|
|
116
PUT
CRISPR Therapeutics
CRSP
$5.17B
| – | – |
-35,000
| Closed | -$2.93M |
|
117
PUT
Carvana
CVNA
$77.9B
| – | – |
-410,000
| Closed | -$18.3M |
|
118
Datadog
DDOG
$84B
| – | – |
-32,100
| Closed | -$3.28M |
|
119
CALL
DraftKings
DKNG
$11.9B
| – | – |
-50,000
| Closed | -$2.94M |
|
120
DexCom
DXCM
$32B
| – | – |
-112,000
| Closed | -$11.5M |
|
|
EB
121
CALL
DELISTED
Eventbrite
EB
| – | – |
-495,000
| Closed | -$5.37M |
|
122
Floor & Decor
FND
$6.68B
| – | – |
-37,500
| Closed | -$2.81M |
|
123
JFrog
FROG
$10.8B
| – | – |
-52,000
| Closed | -$4.4M |
|
|
HOLX
124
DELISTED
Hologic
HOLX
| – | – |
-72,000
| Closed | -$4.79M |
|
125
PUT
Inspire Medical Systems
INSP
$1.74B
| – | – |
-80,000
| Closed | -$10.3M |
|
Similar funds
AGA
ACM
LSA
GWA
HP
SC
IAM
VCM
Atika Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Atika Capital Management held 156 positions worth $1.28B, up 4.6% from $1.22B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Atika Capital Management withdrew a net $177M in Q4 2020, closing 47 positions and reducing 32 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $16M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Atika Capital Management opened a new position in Airbnb worth $20.8M.
- Atika Capital Management's largest Q4 2020 buy was Airbnb: 142,000 shares worth $20.8M.
- Atika Capital Management added most to Natera in Q4 2020, an estimated $6.31M increase.
- Atika Capital Management's biggest Q4 2020 reduction was Amazon, cutting an estimated $17.6M.
- Atika Capital Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020, selling an estimated $16M.
- Atika Capital Management's ten largest holdings make up 24% of its $1.28B portfolio in Q4 2020.
- Atika Capital Management opened 50 new positions and closed 47 in Q4 2020.
- Atika Capital Management's portfolio value rose 4.6% quarter-over-quarter to $1.28B.
Based on Atika Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.